# OnCo record paper-harding-lancet-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-harding-lancet-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-harding-lancet-oncol" ;
  schema:name "Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study"@en ;
  schema:description "Paper cited by one cancer page, indexed on Europe PMC as PubMed record 37276871 and published in The Lancet Oncology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-harding-lancet-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(23)00242-5>, <https://pubmed.ncbi.nlm.nih.gov/37276871/>, <https://europepmc.org/article/MED/37276871> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(23)00242-5> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Harding JJ, Fan J, Oh DY, et al." ;
  onco:related <https://onco.cc/cancers/gallbladder/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .